EPE238 | Cost versus price of key drugs to treat COVID-19, HIV, HBV and HCV | E-poster | Costing of HIV, hepatitis and STI services |
EPE239 | Estimating the costs of comprehensive HIV services for key populations in Kenya and Malawi: an analysis of the LINKAGES program | E-poster | Costing of HIV, hepatitis and STI services |
EPE240 | Economic evaluation of improving HIV self-testing among men who have sex with men in China using a crowdsourced intervention: a cost-effectiveness analysis | E-poster | Costing of HIV, hepatitis and STI services |
EPE241 | The cost of facility-based Index testing HIV case detection in Maharashtra | E-poster | Costing of HIV, hepatitis and STI services |
EPE242 | Cost analysis of virtual outreach model to provide HIV services to key populations in India: an implementation research | E-poster | Costing of HIV, hepatitis and STI services |
EPE243 | Estimating program and patient cost-savings from multi-month ARV dispensing in Vietnam's Social Health Insurance scheme: strengthening scale up decision-making | E-poster | Costing of HIV, hepatitis and STI services |
EPE244 | Use of generic ritonavir-boosted darunavir and dolutegravir for second line antiretroviral therapy is cost-effective in Zambia: a 10-year modelling analysis | E-poster | Costing of HIV, hepatitis and STI services |
EPE245 | Cost of caregiver-assisted oral HIV screening of children in Uganda and Zambia | E-poster | Costing of HIV, hepatitis and STI services |
EPE246 | Costs of pharmacy, workplace and hotspot HIV self-testing in Kenya | E-poster | Costing of HIV, hepatitis and STI services |
EPE247 | Financial cost of a PrEP program among adolescent men who have sex with men and transgender women in Brazil | E-poster | Costing of HIV, hepatitis and STI services |